Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
Singapore Shares Drop in Red Despite Global Rally; Biolidics Surges 20% on Wider Losses in Q1
Singapore's Straits Times Index slipped into the red zone on Wednesday, despite an overnight global rally following US inflation data that topped expectations.
儘管在美國通脹數據超出預期之後，隔夜全球出現反彈，但新加坡海峽時報指數週三跌至紅色區域。
During the day, the benchmark Singapore Strait Times Index ranged between 3,285.45 and 3,309.42, ending 0.72% or 23.93 points lower at 3,289.42.
當天，基準新加坡海峽時報指數在3,285.45至3,309.42點之間，收盤下跌0.72％或23.93點，至3,289.42點。
In economic news, Life insurance in Singapore surged 32% year over year to $1.37 billion in the first quarter of 2024, according to a statement from the Life Insurance Association, Singapore (LIA).
在經濟新聞方面，根據新加坡人壽保險協會（LIA）的一份聲明，新加坡的人壽保險在2024年第一季度同比增長32％，達到13.7億美元。
In company news, Biolidics (SGX:8YY) surged 20% even though the company posted a wider attributable loss in the first quarter after revenue plummeted past 96% from a year earlier.
在公司新聞方面，Biolidics（新加坡證券交易所股票代碼：8YY）飆升了20％，儘管該公司在收入較去年同期暴跌至96％後在第一季度公佈了更大的應占虧損。
Shares of Hyphens Pharma International (SGX:1J5) were up over 9% after the company almost doubled its net profit in the first quarter, thanks to improved sales from all segments, especially in the specialty pharma principals unit.
Hyphens Pharma International（新加坡證券交易所股票代碼：1J5）的股價上漲了9％以上，此前該公司在第一季度的淨利潤幾乎翻了一番，這要歸因於所有細分市場的銷售增長，尤其是特種製藥主要部門的銷售增長。
Oxley Holdings' (SGX:5UX) shares were down nearly 1% after it bought back a further 100,000 shares in the open market on Tuesday as per an existing mandate of up to 212.5 million shares.
奧克斯利控股公司（新加坡證券交易所股票代碼：5UX）根據現有最高2.125億股的授權，週二在公開市場上又回購了10萬股股票，股價下跌了近1％。